MDXH - These Analysts Increase Their Forecasts On MDxHealth After Q4 Results | Benzinga
MDxHealth SA (NASDAQ: MDXH) reported better-than-expected sales for its fourth quarter on Wednesday.
MDxHealth posted quarterly GAAP loss of 39 cents per share, compared to market expectations for a loss of 15 cents per share. The company’s quarterly sales came in at $19.398 million, beating estimates of $18.136 million, according to data from Benzinga Pro.
Michael K. McGarrity, CEO of mdxhealth, said: "Our fourth quarter and full year 2023 results reflect our continued commitment to commercial execution and operational discipline that has driven significant gross margin expansion across our business. With each passing quarter, we continue to build on our position ...